BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 34326843)

  • 1. The Many Faces of JAKs and STATs Within the COVID-19 Storm.
    Grant AH; Estrada A; Ayala-Marin YM; Alvidrez-Camacho AY; Rodriguez G; Robles-Escajeda E; Cadena-Medina DA; Rodriguez AC; Kirken RA
    Front Immunol; 2021; 12():690477. PubMed ID: 34326843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
    Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
    Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis and treatment of cytokine storm in COVID-19.
    Kim JS; Lee JY; Yang JW; Lee KH; Effenberger M; Szpirt W; Kronbichler A; Shin JI
    Theranostics; 2021; 11(1):316-329. PubMed ID: 33391477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
    Solimani F; Meier K; Ghoreschi K
    Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
    Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
    Dzobo K; Chiririwa H; Dandara C; Dzobo W
    OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
    Pum A; Ennemoser M; Adage T; Kungl AJ
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid-19 pathology.
    Al-Ani B; ShamsEldeen AM; Kamar SS; Haidara MA; Al-Hashem F; Alshahrani MY; Al-Hakami AM; Kader DHA; Maarouf A
    Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):483-491. PubMed ID: 35066912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.
    Luo J; Lu S; Yu M; Zhu L; Zhu C; Li C; Fang J; Zhu X; Wang X
    Gene; 2021 Feb; 768():145325. PubMed ID: 33253796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy.
    Satarker S; Tom AA; Shaji RA; Alosious A; Luvis M; Nampoothiri M
    Postgrad Med; 2021 Jun; 133(5):489-507. PubMed ID: 33245005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
    Attiq A; Yao LJ; Afzal S; Khan MA
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dissection of Janus kinases as drug targets for inflammatory diseases.
    Kwon S
    Front Immunol; 2022; 13():1075192. PubMed ID: 36569926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonizing cytokine-mediated JAK-STAT signaling by porcine reproductive and respiratory syndrome virus.
    Yang L; Zhang YJ
    Vet Microbiol; 2017 Sep; 209():57-65. PubMed ID: 28069291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.
    Nystrom SE; Li G; Datta S; Soldano KL; Silas D; Weins A; Hall G; Thomas DB; Olabisi OA
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35472001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
    O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
    Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.